Technician or Research Associate Cell Biology 100%

• Develop and execute cellular assays (e.g. reporter gene assays, flow cytometry-based assays, proliferation assays, PBMCs assays, etc.) to screen and characterize therapeutic antibody candidates
• Generation of high-quality data in cellular assay systems to enable the progressing of Numab’s discovery projects
• Presentation of experimental results within team meetings and company presentations
• Work closely with team members and across research functions to outline next steps and support discovery project teams to move pipeline projects forward
• General organization of the laboratories, evaluation and acquisition of equipment and consumables

• Completed an apprenticeship as a laboratory technician with several years of experience or a higher education in biology, (bio-)chemistry or pharmaceutical sciences
• Industry experience in drug discovery and demonstrated expertise in developing, executing and validating cellular assays
• Initiative, problem solving skills, self-motivation and curiosity 
• Highly accurate and team-oriented working style paired with a high sense of quality 
• Ability to work on diverse tasks independently
• Refined computer user skills (Windows, MS Office) and excellent communication skills
• Experience in programming (e.g. R or Python) as well as lab automation is a plus

• A diverse field of activities in a dynamic team with an inspiring, entrepreneurial atmosphere
• Flat hierarchies and short decision-making paths
• The opportunity to take responsibility, help shaping and implementing solutions
• Attractive employment conditions, superior pension plan, flexible working time model, and opportunities for further personal development
• Performance-based bonus and participation in the employee stock option plan
• Several fun team events throughout the year
• A workplace near the city of Zurich, overlooking the lake

Numab Therapeutics AG is an expanding, Swiss biotech company based in Horgen, canton of Zürich. The company is focused on the discovery and development of innovative, antibody fragment-based therapeutics with a focus on inflammation and immuno-oncology. With our breakthrough antibody-discovery and multi-specifics engineering platform, we engage in proprietary projects as well as collaborative research on behalf of partners in the pharmaceutical industry.